Kanda Sangthongpitag

Wnt addiction of genetically defined cancers reversed by PORCN inhibition

Babita Madan, Zhanbo Ke, Nathan Harmston et al. · Oncogene · 2015 · 339 citations · Full text

Porcn Inhibition, Pathology, Wnt Addiction +16

SB939, a Novel Potent and Orally Active Histone Deacetylase Inhibitor with High Tumor Exposure and Efficacy in Mouse Models of Colorectal Cancer

Veronica Novotny‐Diermayr, Kanda Sangthongpitag, Chang Hu et al. · Molecular Cancer Therapeutics · 2010 · 132 citations · Full text

Liquid Tumors, High Tumor Exposure, Oncology +15

p53 Maintains Genomic Stability by Preventing Interference between Transcription and Replication

Constance Qiao Xin Yeo, Irina Alexander, Zhaoru Lin et al. · Cell Reports · 2016 · 98 citations · Full text

Discovery of (2<i>E</i>)-3-{2-Butyl-1-[2-(diethylamino)ethyl]-1<i>H</i>-benzimidazol-5-yl}-<i>N</i>-hydroxyacrylamide (SB939), an Orally Active Histone Deacetylase Inhibitor with a Superior Preclinical Profile

Haishan Wang, Niefang Yu, Dizhong Chen et al. · Journal of Medicinal Chemistry · 2011 · 91 citations · Full text

Fragment-Based Ligand Design of Novel Potent Inhibitors of Tankyrases

Andreas Larsson, Anna Jansson, Fui Mee Ng et al. · Journal of Medicinal Chemistry · 2013 · 65 citations · Full text

Molecular Docking, Crystal Structure, Medicinal Chemistry +11